Concepedia

Author

Zhiyan Qian

Novartis (Switzerland)

Also Known As

Zhiyan Qian

22

Publications

346

Citations

6

H-Index

14

Concepts

All Affiliations

Novartis (Switzerland)Novartis Institutes for BioMedical Research
ZQ

About

Zhiyan Qian is an author at Novartis (Switzerland) specializing in jak-stat signaling pathway, systems biology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

136

2

Cell Biology

2

2

136

3

Natural Sciences

1

1

126

4

Biochemistry

1

1

126

5

Immunology

1

1

10

Zhiyan Qian

×

6

Publications

346

Citations

6

H-Index

YearCitations

Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent

Rita Andraos, Zhiyan Qian, Débora Bonenfant,

Cancer Discovery

2012

126

Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue

Patrick Chêne, Joëlle Rudloff, Joseph Schoepfer,

BMC Chemical Biology

2009

81

JAK1/2 and Pan-Deacetylase Inhibitor Combination Therapy Yields Improved Efficacy in Preclinical Mouse Models of JAK2V617F-Driven Disease

Emeline Evrot, Nicolas Ebel, Vincent Romanet,

Clinical Cancer Research

2013

76

Improved Efficacy Upon Combined JAK1/2 and Pan-Deacetylase Inhibition Using Ruxolitinib (INC424) and Panobinostat (LBH589) in Preclinical Mouse Models of JAK2V617F-Driven Disease

Fabienne Baffert, Emeline Evrot, Nicolas Ebel,

Blood

2011

28

Bim and Mcl-1 exert key roles in regulating JAK2V617Fcell survival

Joëlle Rubert, Zhiyan Qian, Rita Andraos,

BMC Cancer

2011

25

A conditional inducible JAK2V617F transgenic mouse model reveals myeloproliferative disease that is reversible upon switching off transgene expression

Emilie A. Chapeau, Emeline Mandon, Jason Gill,

PLoS ONE

2019

10

Page 1